STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

NEPH NEPHROS INCORPORATED StockScouter® Report

7

StockScouter® Score

NEPHROS INCORPORATED, a micro cap growth company in the capital goods sector, is expected to slightly outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Moving average analysis for NEPH suggests upward price movement over the medium term. Positive
  • Short-term relative price momentum exhibits moderate strength. Postive/Neutral

 

Concerns

  • Shares are being sold by financial institutions. Slightly negative for a small company like NEPH
  • The multi-period measure of relative price change and consistency is average. Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, growth stocks will be out of favor, and capital goods stocks will be out of favor.

Expected Risk/Return

Progress: 60% done.
Progress: 80% done.
Low
High

Core Model Grades

C
C
C
C

Previous Ratings

6
7
4